Verified factor-similar pair

ISCV vs JHSC

These US-listed equity ETFs share verified FF6 US factor exposure. The modeled volatility of their factor-return difference is at or below 3% annualized on both the same 36-month window and a longer factor-history check.

SMB
Current similarity score
82
Factor-similar

The score is 100 for identical fitted exposures and 80 at the 3% modeled tracking-error limit. It includes market and non-market factors; it does not indicate which fund earned or is expected to earn more. How to read this score.

Quick Read

  • ISCV has the higher backtested relative Sharpe (0.853 vs 0.639).
  • ISCV has the lower published fee (0.06% vs 0.46%).
  • JHSC is cheaper on dividend valuation (100 vs 111, where 100 is each fund's historical median).
  • ISCV has the stronger regression fit (adjusted R-squared 0.969 vs 0.963).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

ISCV

iShares Morningstar Small Cap Value ETF
SMB HML
Adj. R2
0.969
Rel. Sharpe
0.853
Mkt beta
0.99
AUM
US$631M
MER
0.06%
Valuation
111

JHSC

John Hancock Multifactor Small Cap ETF
SMB
Adj. R2
0.963
Rel. Sharpe
0.639
Mkt beta
1.03
AUM
US$703M
MER
0.46%
Valuation
100

Market beta uses the common 36-month window through 2026-08. Adjusted R² and relative Sharpe describe each fund's separately published full-history model.

Factor Exposure Match

Blue bars compare factor beta magnitude from the same 36 months shown above. Green bars compare absolute t-stat strength; dim bars indicate |t| below 1.96. Every factor enters the distance calculation regardless of its t-statistic.

SMB
ISCV
+0.70
|t|
+13.3
JHSC
+0.61
|t|
+8.4
diff +0.09
HML
ISCV
+0.43
|t|
+7.0
JHSC
+0.36
|t|
+4.3
diff +0.07
RMW
ISCV
+0.06
|t|
+1.3
JHSC
+0.07
|t|
+1.1
diff -0.01
CMA
ISCV
+0.15
|t|
+2.2
JHSC
+0.16
|t|
+1.7
diff -0.01
UMD
ISCV
-0.05
|t|
-1.4
JHSC
+0.09
|t|
+1.9
diff -0.13

What Happened Over the Same 36 Months

ISCV adjusted total-return CAGR
15.65%
JHSC adjusted total-return CAGR
13.63%

ISCV ahead by 2.02 percentage points/year over 2023-09 through 2026-08. This is the observed difference between annualized compounded returns from adjusted prices, not an expected return or a factor-model estimate.

Historical factor attribution

Signed contribution to ISCV minus JHSC, percentage points/year, using fitted 36-month exposures and average factor returns over those same months:

Market factor
-0.65
Other factors, combined
-0.74
Total factor-implied difference
-1.38

This arithmetic-average factor attribution excludes the regression intercept and fund-specific return. It therefore need not equal the observed CAGR difference and is not a forecast.

Why This Pair Matches

Modeled factor tracking error · 36m
2.74%/yr
Modeled tracking error · 120m factor history
2.71%/yr
Mkt beta diff
0.04
Rel. Sharpe diff
0.214

Fitted exposures and factor covariance estimate the volatility, not the average or direction, of the funds' modeled return difference. The common regression window is 2023-09 through 2026-08. A short-window estimate and a longer factor-history check must both be at or below 3.000%; this is a screening limit, not a forecast. Holdings, turnover, taxes and trading costs require a separate review. The Sharpe figures elsewhere on this page come from each fund's published full-history model and do not enter similarity ranking. See the full methodology.

ISCV fund page JHSC fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.